Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
NCT07624903Phase 2Not yet recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of letrozole in Ectopic pregnancy (EP) (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Resolution of complain. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
letrozole
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT07624903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624903.